amikacin has been researched along with Disease Exacerbation in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Charbek, E; Rowbotham, NJ; Smith, S | 1 |
| Kato, T; Nakayama, H; Suzuki, M; Usuki, K | 1 |
| Chae, JY; Kim, JW; Moon, du G; Oh, MM; Park, MG; Yoon, CY | 1 |
| Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT | 1 |
| Prescott, WA | 1 |
| Jahnke, N; Remmington, T; Ryan, G | 1 |
| Bespalova, IA; Bugaeva, OK; Goncharov, EK; Makarovskaia, LN; Malsova, NN; Pavlovich, NV; Ryzhkova, VV; Zurabian, VA | 1 |
| Chabry, J; Gautier, N; Nicolas, S; Pisani, DF; Rochet, N | 1 |
3 review(s) available for amikacin and Disease Exacerbation
| Article | Year |
|---|---|
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Cystic Fibrosis; Disease Progression; Forced Expiratory Volume; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Ticarcillin; Tobramycin | 2018 |
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides.
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Child; Cystic Fibrosis; Disease Progression; Gentamicins; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2013 |
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Cystic Fibrosis; Disease Progression; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Ticarcillin; Tobramycin | 2012 |
5 other study(ies) available for amikacin and Disease Exacerbation
| Article | Year |
|---|---|
Amikacin Pharmacokinetics in Terminal Stage of Hematological Malignancy.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Creatinine; Disease Progression; Female; Hematologic Neoplasms; Humans; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Young Adult | 2019 |
Positive culture for extended-spectrum β-lactamase during acute prostatitis after prostate biopsy is a risk factor for progression to chronic prostatitis.
Topics: Aged; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Blood; Cefoxitin; Disease Progression; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Image-Guided Biopsy; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prostate; Prostatitis; Quinolones; Urine | 2013 |
A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cystic Fibrosis; Disease Progression; Drug Administration Schedule; Drug Monitoring; Gentamicins; Health Care Surveys; Humans; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Tobramycin; United States | 2014 |
[Increased effectiveness of etiotropic therapy of experimental plague in albino mice at the stage of generalized infection].
Topics: Amikacin; Animals; Anti-Infective Agents; Ciprofloxacin; Disease Progression; Drug Evaluation, Preclinical; Gentamicins; Mice; Plague; Polymyxins; Rifampin | 1996 |
The adiponectin receptor agonist AdipoRon normalizes glucose metabolism and prevents obesity but not growth retardation induced by glucocorticoids in young mice.
Topics: Abdominal Fat; Animals; Bone Development; Carbohydrate Metabolism; Disease Models, Animal; Disease Progression; Glucocorticoids; Glucose; Growth Disorders; Male; Mice; Mice, Inbred C57BL; Obesity; Piperidines; Receptors, Adiponectin | 2020 |